CytomX Therapeutics (CTMX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings estimates, which ...

Investors might want to bet on NCR Atleos (NATL), as it has been recently upgraded to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces impacting ...

Analysts are showing growing confidence in European and Chinese tech stocks as they outperform the S&P 500 (SPX). Many ...

Much of the fear driving the sell-off is a potential trade war triggered by President Donald Trump's tariffs (or threat of ...

GE Vernova is poised for strong revenue and earnings growth due to a solid backlog. Read why I maintain my buy rating on GEV ...

Quality dividend stocks yielding 7% and more are the best ideas for many investors now. These five are too cheap to ignore ...

NuScale Power (SMR) stock is down over 30% in the past month, catalyzed by a reported year-over-year rise in net losses from ...

Durect (DRRX) could be a solid choice for investors given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates ...

PennantPark (PFLT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). An upward trend in earnings estimates -- one of the most powerful forces ...